ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07-12 07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 57,462 shares, the number of shares held increased 5.13% compared to the previous period and now represents 1.09% of the total position.
      20Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-12 07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 82,101 shares, the number of shares held decreased 4.7% compared to the previous period and now represents 2.87% of the total position.
      31Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-12 07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 60,891 shares, the number of shares held decreased 4.3% compared to the previous period and now represents 7.51% of the total position.
      97Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-12 07:13
      ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 16,105 shares, the number of shares held decreased 3.43% compared to the previous period and now represents 4.4% of the total position.
      11Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-12 07:13
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 105,364 shares, the number of shares held increased 37.65% compared to the previous period and now represents 1.46% of the total position.
      1.65KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-12 07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 544,385 shares, the number of shares held increased 10.92% compared to the previous period and now represents 1.38% of the total position.
      220Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-12 07:13
      ARKG Investment Tracker position change: Increased position in COMPASS Pathways plc by 46,302 shares, the number of shares held increased 1.35% compared to the previous period and now represents 2.8% of the total position.
      3Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-12 07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 4,889 shares, the number of shares held decreased 2% compared to the previous period and now represents 3.98% of the total position.
      38Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-12 07:13
      ARKG Investment Tracker position change: Decreased position in Personalis by 31,889 shares, the number of shares held decreased 0.42% compared to the previous period and now represents 6.53% of the total position.
      74Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-12 07:13
      ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 8,712 shares, the number of shares held increased 0.065% compared to the previous period and now represents 2.98% of the total position.
      847Comment
      Report
     
     
     
     

    Most Discussed